Estradiol
Drugoral 2mg tablet of estradiol
Other names: Estrace
NCT Number: NCT07737613
The goal of current study is to better understand how fear is processed in the brain and how these processes are influenced by cognition and hormones. This research will focus specifically on postmenopausal female adults, because age-related changes in cognition and declining estrogen levels may contribute to anxiety symptoms and PTSD risk later in life.
Trial opening soon.
Get Notified60 year and older
Female
Interventional
Early Phase 1
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
oral 2mg tablet of estradiol
Other names: Estrace
Time frame: single visit, approximately 4 hours after taking study drug
Estrogen has been shown to modulate the function of brain regions involved in fear processing, including the amygdala, hippocampus, and ventromedial prefrontal cortex. During fMRI, participants will complete a fear conditioning and generalization task to measure brain activity. They will view different neutral images of geometric shapes which may or may not predict the imminent receipt of an electric shock to the ankle. Across voxels of the brain, activation estimates (BOLD response) will be extracted for CS+ (conditioned threat) vs. CS- (conditioned safety) cues, and linear activation patterns across ambiguous generalization stimuli (i.e., GSs; CS+ > GS1 > GS2 > GS3 > CS-).
Time frame: single visit, approximately 4 hours after taking study drug
Sweat glands activate under stress, increasing the electrical conductance of the skin. Participants will have electrodes attached on their palm to measure changes in sympathetic nervous system activity, providing an objective, physiological measure of anticipatory anxiety.
Time frame: single visit, approximately 4 hours after taking study drug
Self-report can be used to ascertain subjective fear and explicit knowledge of threat contingencies. Participants will be asked to rate of perceived risk of each displayed stimulus from 1 (no risk) to 3 (high risk), contingency learning, and aversiveness of the stimulation (1-5) during task completion in the scanner and after.
Contact information is provided by the study sponsor or research team.
University of Arizona
Other
Neuroimaging Study of Fear Learning: Effects of Estrogen
Acronym: EstroFearGen
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07563296
Mental Disorders, PTSD and Trauma-related Symptoms
Salt Lake City, Utah, United States
View Trial DetailsNCT06983002
Affect Consciousness, Borderline Personality Disorder
Stavanger, Rogaland, Norway
View Trial DetailsNCT05821634
Alcohol-Related Disorders, Alcohol; Use, Problem; Alcohol Use Disorder
Piscataway, New Jersey, United States
View Trial DetailsNCT07420478
Autism, Autism Spectrum Disorder
Lebanon, New Hampshire, United States
View Trial Details